Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals
- PMID: 17368800
- DOI: 10.1016/j.diagmicrobio.2006.11.009
Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals
Abstract
Candida tropicalis is the 2nd most frequent agent of candidemia in Brazil (20-24%). We attempted to characterize the epidemiology, microbiology, and outcome of candidemia due to C. tropicalis by comparing patients with candidemia due to C. tropicalis with those with candidemia due to Candida albicans. Among the 924 episodes of candidemia, 188 (20%) were caused by C. tropicalis. These cases were compared with 384 candidemias due to C. albicans. C. tropicalis was the 2nd most frequent species in adults (21.6%) and elderly patients (23.2%), and 3rd in neonates (11.9%) and children (18.5%). Cancer was the most frequent underlying disease, and in adults and elderly patients, diabetes was the 2nd most frequent underlying disease. The only difference between C. tropicalis and C. albicans candidemia was a higher proportion of neutropenic patients in C. tropicalis candidemia. C. tropicalis is a leading cause of candidemia in Brazil, and its epidemiology is similar to that of C. albicans.
Similar articles
-
Epidemiology of candidemia in a tertiary care centre of north India: 5-year study.Infection. 2007 Jun;35(4):256-9. doi: 10.1007/s15010-007-6144-6. Epub 2007 Jul 23. Infection. 2007. PMID: 17646917
-
Epidemiology of candidemia at a Children's hospital, 2002 to 2006.Pediatr Infect Dis J. 2009 Sep;28(9):806-9. doi: 10.1097/INF.0b013e3181a0d78d. Pediatr Infect Dis J. 2009. PMID: 19636286
-
Distribution of Candida species among bloodstream isolates.Saudi Med J. 2004 May;25(5):566-9. Saudi Med J. 2004. PMID: 15138521
-
Epidemiology of candidemia in intensive care units.Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S87-91. doi: 10.1016/S0924-8579(08)70006-2. Int J Antimicrob Agents. 2008. PMID: 19013346 Review.
-
Insights into Candida tropicalis nosocomial infections and virulence factors.Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1399-412. doi: 10.1007/s10096-011-1455-z. Epub 2011 Oct 30. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22037823 Review.
Cited by
-
Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.Mycopathologia. 2013 Dec;176(5-6):409-15. doi: 10.1007/s11046-013-9705-5. Epub 2013 Oct 11. Mycopathologia. 2013. PMID: 24113801
-
Protein kinase A governs growth and virulence in Candida tropicalis.Virulence. 2018 Jan 1;9(1):331-347. doi: 10.1080/21505594.2017.1414132. Virulence. 2018. PMID: 29254431 Free PMC article.
-
A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade.Infection. 2013 Jun;41(3):655-62. doi: 10.1007/s15010-013-0455-6. Epub 2013 Apr 5. Infection. 2013. PMID: 23559357
-
Development of Echinocandin Resistance in Candida tropicalis following Short-Term Exposure to Caspofungin for Empiric Therapy.Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01926-17. doi: 10.1128/AAC.01926-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29437623 Free PMC article.
-
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Front Microbiol. 2017 Jan 12;7:2173. doi: 10.3389/fmicb.2016.02173. eCollection 2016. Front Microbiol. 2017. PMID: 28127295 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical